Your only source for JOINT-ACCREDITED SoMe-delivered, serialized professional cardiometabolic education. Physicians, nurses, pharmacists--come one, come all!
4 subscribed
Sep 19 • 44 tweets • 15 min read
1) Welcome to a 🆕#accredited tweetorial on Recent Advances in the Risk Assessment in Patients with Hyperlipidemia: Enhancing Precision and Reliability. Our expert faculty is Dr Nataliya Pyslar @NP_ltl_a, #Cardiologist& Lipid Specialist @CookCtyHealth.
#Cardiotwitter #FOAMed 2) This presentation was originally delivered by @NP_ltl_a at an accredited satellite symposium at @nationallipid's June 2023 congress. She shared the podium there with lipidology & #preventive #cardiology experts @alanbrownmd, @jpenamd, & @lipiddoc.
@MedTweetorials
Jul 5 • 41 tweets • 11 min read
1) Welcome to a 🆕#accredited #tweetorial & another opportunity to earn 🆓CE/#CME! Just follow this 🧵as returning expert author Ph.Gabriel Steg @gabrielsteg 🇫🇷 discusses the basics of #HCM along with special considerations for the #interventionalist.
#FOAMed #CardioTwitter https://t.co/zVfX7HWbg0twitter.com/i/web/status/1… 2) This program is intended for #HCPs & is supported by an unrestricted educational grant from Bristol Myers Squibb. Statement of accreditation and faculty disclosures at .
FOLLOW US for expert-authored #cardiometabolic programs for 🆓CE/#CMEcardiometabolic-ce.com/disclosures/
Jun 24 • 24 tweets • 9 min read
1a) Welcome to a live-tweeted, #accredited #tweetorial from #ADA23 @AmDiabetesAssn in #SanDiego on advances in #hyperlipidemiamanagement #LLT. Our expert returning faculty is Christopher Cannon, MD @cpcannon #cardiologist from @harvardmed & @BrighamWomens.
#CardioTwitter #MedEd
1b) Patients with #diabetes #PWDs are of course at substantially increased risk of #CV disease, often in association with hyperlipidemia #HL. Therefore it's no surprise that a 🌶️topic at #ADA23 would be management of #HL and #CV disease prevention!
#FOAMed @MedTweetorials
1) Welcome to Part 2 of a new #accredited#tweetorial in our series of educational programs on #hypertrophic#cardiomyopathy#HCM. DOn't miss Part 1, still available for 🆓CE/#CME, at cardiometabolic-ce.com/hcm5a/.
Now you can learn more, and EARN MORE credit, by following this 🧵!
2) Our expert author is again Sergio Kaiser MD PhD FACC FESC 🇧🇷🇮🇱 @pabeda1, cardiologist 🫀, Professor 🎓 of #InternalMedicine, Rio de Janeiro State University. He brings the general cardiologist's perspective to our #HCM discussions. Read and learn! #FOAMed#CardioTwitter
1a) Welcome to a new #accredited#tweetorial on the management of aFXa-DOAC-associated #hemorrhage and specifically the role of coag laboratory testing in these challenging cases.
1b) Our expert author is #pharmacist Craig Beavers, PharmD @beaverspharmd CV Clinical Pharmacy Specialist @UK_COP, and Immediate Past Chair of the @ACCinTouch#ACCCVT Section
Join us tomorrow for the launch of a new #accredited#tweetorial on the primary care management of #hyperlipidemia covering the relationship between #LDL_C & major #CV events, CV risk categories, recommended LDL-C treatment goals, & oral therapeutic options for lipid-lowering
1) Welcome to a new #tweetorial on the primary care management of #hyperlipidemia. Our returning @cardiomet_CE expert author is dedicated #SoMe education advocate Kevin Fernando, FRCGP FRCP Edin, FAcadMEd MSc Diabetes @drkevinfernando
1) Welcome to a new #accredited#tweetorial on Clinical and Laboratory Manifestations of #DKD in #T2D: From Early Identification to Monitoring Management. Your expert author is @edgarvlermamd.
2a) This activity is supported by an independent educational grant from the Boehringer Ingelheim/Lilly Alliance and is intended for healthcare providers. It is accredited for #physicians#physicianassistants#nurses#NPs#pharmacists. Check out @cardiomet_ce for more🆓CE/#CME.